Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 1IIT 1-Year Double-Blind Placebo-Controlled Study To EVALUATE THE EFFECT OF AGE ZERO™ EXOSOMES ON HAIR REGROWTH IN HEALTHY MEN AND WOMEN WITH ANDROGENETIC ALOPECIA
The purpose of this study is to determine whether Wharton's Jelly mesenchymal stem cell-derived exosome microneedling on the scalp is an effective treatment for Androgenetic Alopecia (pattern hair loss).
100 Clinical Results associated with RESILIÉLLE COSMETICS LLC.
0 Patents (Medical) associated with RESILIÉLLE COSMETICS LLC.
100 Deals associated with RESILIÉLLE COSMETICS LLC.
100 Translational Medicine associated with RESILIÉLLE COSMETICS LLC.